Shattuck Labs, Inc.

NASDAQ:STTK

Biotechnology

Healthcare
$4.55 +2.33%

+$0.11 today

Market cap
$463.38M
Beta
1.09
P/E (TTM)
-10.9
EPS (TTM)
-$0.44
52W Low $0.71High $8.33

Volume 1.39M

Average 0.69M

STTK Account Payables

Amounts the company owes suppliers for goods and services received.

Shattuck Labs, Inc.NASDAQ: STTK

Account Payables · Q1 FY2026 · quarter ended Mar 2026

Account payables falls 18.3% from a year ago

Account payables stood at $1.25M at the end of Q1 FY2026, down 18.3% from a year earlier and down 40.4% from the prior quarter. Over 3 fiscal years it compounded at -33.6% a year.

Context

  • Account payables amounted to 1.2% of total assets at the end of Q1 FY2026, down 0.8 pp from a year earlier.
  • Account payables increased in 1 of the last 3 fiscal years.

What to watch

Whether account payables keeps falling in the next quarterly balance sheet after a -18.3% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.25M-40.4% QoQ
Last fiscal yearDec 2025
$2.1M-13.1% YoY
Year agoMar 2025
$1.53M-18.3% since
Account Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-18.3%——
1 year-13.1%——
3-year CAGR-33.6%——
5-year CAGR——
10-year CAGR——

Account Payables history

USD · from the balance sheet

Latest · FY2025
2.1M USD
Year-over-year change
-13.1%
4-year CAGR
-32.3%

Account Payables vs competitors

How STTK compares with its peers on the latest reported figures

  • STTK's Mar 2026 account payables of $1.25M is the 7th highest of the 10 companies compared; the peer median is $2.15M.
  • Its year-over-year change of -18.3% is the 7th highest of 9, against a peer median of +20.3%.
  • Account payables amounts to 1.2% of total assets for STTK, versus a peer median of 2.2%.
STTK Competitors Peer median
Account Payables for STTK and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
IOVAIovance Biotherapeutics, Inc.Sep 2026$21.65M -30.7%-5.9%2.2%
PBYIPuma Biotechnology, Inc.Mar 2026$8.17M +35.5%-7.7%4.2%
PDSBPDS Biotechnology CorporationMar 2026$3.65M +27.7%+43.1%14.8%
BDTXBlack Diamond Therapeutics, Inc.Mar 2026$2.97M +13.0%-32.4%2.2%
FTHFaeth Therapeutics, Inc.Jun 2026$2.15M +511.7%-46.4%1.1%
SLSSELLAS Life Sciences Group, Inc.Sep 2026$2.09M -9.4%-4.2%1.5%
STTKShattuck Labs, Inc.Mar 2026$1.25M -18.3%-33.6%1.2%
CBIOCrescent Biopharma, Inc.Mar 2026$1.19M +702.7%+117.6%0.6%
INDPIndaptus Therapeutics, Inc.Mar 2026$557.37K -57.5%-26.6%25.6%
NBPNovaBridge BiosciencesDec 2025$0 ——0.0%
Peer median (excluding STTK) $2.15M+20.3%-6.8%2.2%

Competitors are the stored peer set for STTK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents92.27M47.38M125.63M57.39M54.19M
Short-term Investments176.54M113.9M5M15.6M23.87M
Net Receivables00000
Inventory00000
Other Current Assets023.3M12.6M6.23M4.41M
Total Current Assets288.27M184.58M143.22M79.22M82.48M
Property, Plant & Equipment (Net)9.94M17.67M13.8M9.81M6.11M
Goodwill00000
Intangible Assets00000
Long-term Investments00001M
Tax Assets00000
Other Non-current Assets381K3.07M2.54M2.02M1.44M
Total Non-current Assets10.32M20.74M16.34M11.83M8.55M
Total Assets298.59M205.32M159.56M91.05M91.03M
Account Payables10.01M7.17M1.59M2.42M2.1M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities11.25M5.84M4.84M2.7M3M
Total Current Liabilities24.59M24.97M11.45M8.92M7.05M
Long-term Debt00001.58M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities2.21M0000
Total Non-current Liabilities2.21M4.2M3.41M2.51M1.58M
Total Liabilities26.8M29.17M14.86M11.42M8.64M
Common Stock5K5K5K5K7K
Retained Earnings(117.07M)(219.01M)(306.31M)(381.72M)(430.53M)
Accumulated OCI(560K)(877K)4K2K6K
Other Stockholders Equity00000
Minority Interest00000
Total Equity271.79M176.16M144.71M79.63M82.39M
Total Debt04.9M4.2M3.41M2.42M
Net Debt(92.27M)(42.48M)(121.42M)(53.98M)(51.77M)

Shattuck Labs, Inc.

NASDAQ:STTK

Intrinsic Alpha fair value

Locked

Current Price

$4.55

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.